fashion -WSS

fashion

author：fashion 2025-09-27 23:02:04 - browse：2

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Biotech lab space demand falls sharply

WSS

Second xenotransplant done with gene

CDC's new outbreak response network to include Northeastern

Intarcia’s device

Ukraine and a new approach to mental health in war

The PBM ad wars are taking over Washington, D.C.

How AI helped researchers track recovery from depression

focus

fashion

focus

Hollywood unions extend contract negotiations for actors

California man arrested in connection with serial murders of Mexican strip club workers

How one medical school became remarkably diverse

Thermo Fisher plant for manufacturing gene therapies to expand

Novavax promises a turnaround & Lilly roils the obesity market

Another man arrested in connection with shooting at Kansas nightclub

Duchenne breakthrough therapy leaves behind pioneering families

How redistricting in 6 states could affect who controls Congress

Medical records are filled with copy

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

hotspot

Ukraine and a new approach to mental health in war

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

Drug for rare kidney disease narrowly misses mark in clinical trial

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Senators: Long

How Vertex's cystic fibrosis drug is changing patients' lives

focus

leisure time

leisure time

Wikipedia